While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...
New medicines, access to treatments, infectious disease monitoring, and more are on the table. View on euronews ...
Johnson & Johnson announced the submission of regulatory applications to the U.S. FDA and European Medicines Agency seeking approval of a ...
RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Volunteer veterinarians in eastern Spain's flood-hit Paiporta are treating pets that have caught infections from the ...
For those with lupus, Botox has a heightened risk of side effects. It can also interact with your lupus medications, so it's best to discuss with your doctor first.
In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...